Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
BioNTech starts Covid-19 vaccine production at new Marburg plant
Wed, 10th Feb 2021 15:30
(Sharecast News) - BioNTech has started production of its Covid-19 vaccine from a new manufacturing site in Marburg, Germany.
At full capacity, the new installation will be able to make 750m doses of the vaccine annually, with the first distribution of vaccines from Marburg currently penciled-in for April.
Together with Pfizer, its partner in developing the vaccine, BioNTech is targeting full-year vaccine production of 2bn doses.
BioNTech's expected vaccine output in the first half of 2021 is expected to reach 250m doses.
Biontech Se Adr
At full capacity, the new installation will be able to make 750m doses of the vaccine annually, with the first distribution of vaccines from Marburg currently penciled-in for April.
Together with Pfizer, its partner in developing the vaccine, BioNTech is targeting full-year vaccine production of 2bn doses.
BioNTech's expected vaccine output in the first half of 2021 is expected to reach 250m doses.
Biontech Se Adr Shares in this article
Latest News
- UK shareholder meetings calendar - next 7 days
3 mins ago - UK dividends calendar - next 7 days
5 mins ago - UK earnings, trading statements calendar - next 7 days
6 mins ago - Russian sanctions waiver extension shows G7 does not agree on everything, EU's Dombrovskis says
14 mins ago - Dr Martens' turnaround gathers pace as annual profit rebounds
16 mins ago - Portugal cabin crew union to join June 3 national strike
22 mins ago - Cost of UK's HS2 rail project soars to $138 billion, minister says
24 mins ago
Related News
20 May 2025
BioNTech to invest up to £1bn in UK R&D expansion
(Sharecast News) - BioNTech announced on Tuesday that it will invest up to £1bn over the next decade to expand its research and development footp...
4 Jun 2021
UK approves Pfizer-BioNTech Covid-19 vaccine shot for use in 12-15 year olds
(Sharecast News) - Britain has approved the Covid-19 vaccine jointly developed by Pfizer-BioNTech for use in children ages 12 to 15.
17 Feb 2021
Pfizer-BioNTech to supply EU with additional 200m doses of Covid-19 vaccine
(Sharecast News) - Pfizer and BioNTech have agreed to supply the European Union with an additional 200 million doses of their Covid-19 vaccine.
Follow the stocks
